Logo image of DRD

DRDGOLD LTD-SPONSORED ADR (DRD) Stock Fundamental Analysis

NYSE:DRD - New York Stock Exchange, Inc. - US26152H3012 - ADR - Currency: USD

15.1255  +0.63 (+4.31%)

Fundamental Rating

7

Overall DRD gets a fundamental rating of 7 out of 10. We evaluated DRD against 153 industry peers in the Metals & Mining industry. While DRD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. DRD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

9

1. Profitability

1.1 Basic Checks

DRD had positive earnings in the past year.
DRD had a positive operating cash flow in the past year.
In the past 5 years DRD has always been profitable.
Each year in the past 5 years DRD had a positive operating cash flow.
DRD Yearly Net Income VS EBIT VS OCF VS FCFDRD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B 1.5B

1.2 Ratios

DRD's Return On Assets of 16.57% is amongst the best of the industry. DRD outperforms 95.42% of its industry peers.
DRD has a better Return On Equity (22.26%) than 92.16% of its industry peers.
With an excellent Return On Invested Capital value of 16.79%, DRD belongs to the best of the industry, outperforming 96.08% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for DRD is significantly above the industry average of 8.54%.
The last Return On Invested Capital (16.79%) for DRD is above the 3 year average (14.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 16.57%
ROE 22.26%
ROIC 16.79%
ROA(3y)15.22%
ROA(5y)15.9%
ROE(3y)20.12%
ROE(5y)21.19%
ROIC(3y)14.11%
ROIC(5y)15.97%
DRD Yearly ROA, ROE, ROICDRD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

DRD's Profit Margin of 24.19% is amongst the best of the industry. DRD outperforms 92.81% of its industry peers.
In the last couple of years the Profit Margin of DRD has grown nicely.
The Operating Margin of DRD (30.64%) is better than 86.93% of its industry peers.
DRD's Operating Margin has improved in the last couple of years.
The Gross Margin of DRD (33.38%) is better than 73.20% of its industry peers.
DRD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 30.64%
PM (TTM) 24.19%
GM 33.38%
OM growth 3Y-9.2%
OM growth 5Y41.5%
PM growth 3Y-7.98%
PM growth 5Y49.6%
GM growth 3Y-6.69%
GM growth 5Y30.15%
DRD Yearly Profit, Operating, Gross MarginsDRD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), DRD is destroying value.
The number of shares outstanding for DRD remains at a similar level compared to 1 year ago.
The number of shares outstanding for DRD has been increased compared to 5 years ago.
The debt/assets ratio for DRD has been reduced compared to a year ago.
DRD Yearly Shares OutstandingDRD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DRD Yearly Total Debt VS Total AssetsDRD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

A Debt/Equity ratio of 0.00 indicates that DRD is not too dependend on debt financing.
The Debt to Equity ratio of DRD (0.00) is better than 82.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.99
WACC16.9%
DRD Yearly LT Debt VS Equity VS FCFDRD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

DRD has a Current Ratio of 2.34. This indicates that DRD is financially healthy and has no problem in meeting its short term obligations.
DRD's Current ratio of 2.34 is in line compared to the rest of the industry. DRD outperforms 53.59% of its industry peers.
DRD has a Quick Ratio of 1.63. This is a normal value and indicates that DRD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of DRD (1.63) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.63
DRD Yearly Current Assets VS Current LiabilitesDRD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 28.36% over the past year.
DRD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 67.77% yearly.
The Revenue has grown by 21.52% in the past year. This is a very strong growth!
The Revenue has been growing by 17.70% on average over the past years. This is quite good.
EPS 1Y (TTM)28.36%
EPS 3Y-2.81%
EPS 5Y67.77%
EPS Q2Q%64.61%
Revenue 1Y (TTM)21.52%
Revenue growth 3Y5.8%
Revenue growth 5Y17.7%
Sales Q2Q%27.84%

3.2 Future

Based on estimates for the next years, DRD will show a very strong growth in Earnings Per Share. The EPS will grow by 29.31% on average per year.
Based on estimates for the next years, DRD will show a quite strong growth in Revenue. The Revenue will grow by 10.96% on average per year.
EPS Next Y20.31%
EPS Next 2Y22.2%
EPS Next 3Y29.31%
EPS Next 5YN/A
Revenue Next Year21.11%
Revenue Next 2Y12.92%
Revenue Next 3Y10.96%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DRD Yearly Revenue VS EstimatesDRD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B
DRD Yearly EPS VS EstimatesDRD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 14.01, which indicates a correct valuation of DRD.
Based on the Price/Earnings ratio, DRD is valued cheaply inside the industry as 87.58% of the companies are valued more expensively.
DRD's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.10.
With a Price/Forward Earnings ratio of 12.12, DRD is valued correctly.
76.47% of the companies in the same industry are more expensive than DRD, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of DRD to the average of the S&P500 Index (20.74), we can say DRD is valued slightly cheaper.
Industry RankSector Rank
PE 14.01
Fwd PE 12.12
DRD Price Earnings VS Forward Price EarningsDRD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DRD Per share dataDRD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of DRD may justify a higher PE ratio.
A more expensive valuation may be justified as DRD's earnings are expected to grow with 29.31% in the coming years.
PEG (NY)0.69
PEG (5Y)0.21
EPS Next 2Y22.2%
EPS Next 3Y29.31%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.82%, DRD has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.93, DRD pays a bit more dividend than its industry peers.
Compared to the average S&P500 Dividend Yield of 2.43, DRD is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.82%

5.2 History

DRD has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of DRD decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
DRD Yearly Dividends per shareDRD Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

20.16% of the earnings are spent on dividend by DRD. This is a low number and sustainable payout ratio.
DP20.16%
EPS Next 2Y22.2%
EPS Next 3Y29.31%
DRD Yearly Income VS Free CF VS DividendDRD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B
DRD Dividend Payout.DRD Dividend Payout, showing the Payout Ratio.DRD Dividend Payout.PayoutRetained Earnings

More info and screens

DRDGOLD LTD-SPONSORED ADR

NYSE:DRD (5/6/2025, 2:59:25 PM)

15.1255

+0.63 (+4.31%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-18 2025-02-18/bmo
Earnings (Next)08-19 2025-08-19/bmo
Inst Owners14.5%
Inst Owner Change2.04%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.30B
Analysts42.86
Price Target11.21 (-25.89%)
Short Float %3.19%
Short Ratio2.38
Dividend
Industry RankSector Rank
Dividend Yield 1.82%
Yearly Dividend0.46
Dividend Growth(5Y)N/A
DP20.16%
Div Incr Years1
Div Non Decr Years1
Ex-Date03-14 2025-03-14 (0.165399)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-4.31%
PT rev (3m)8.03%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-3.68%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.49%
Valuation
Industry RankSector Rank
PE 14.01
Fwd PE 12.12
P/S 3.38
P/FCF N/A
P/OCF 9.99
P/B 3.11
P/tB 3.11
EV/EBITDA N/A
EPS(TTM)1.08
EY7.14%
EPS(NY)1.25
Fwd EY8.25%
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)1.51
OCFY10.01%
SpS4.48
BVpS4.86
TBVpS4.86
PEG (NY)0.69
PEG (5Y)0.21
Profitability
Industry RankSector Rank
ROA 16.57%
ROE 22.26%
ROCE 22.53%
ROIC 16.79%
ROICexc 18.04%
ROICexgc 18.04%
OM 30.64%
PM (TTM) 24.19%
GM 33.38%
FCFM N/A
ROA(3y)15.22%
ROA(5y)15.9%
ROE(3y)20.12%
ROE(5y)21.19%
ROIC(3y)14.11%
ROIC(5y)15.97%
ROICexc(3y)19.7%
ROICexc(5y)23.63%
ROICexgc(3y)19.7%
ROICexgc(5y)23.63%
ROCE(3y)18.93%
ROCE(5y)21.41%
ROICexcg growth 3Y-26.45%
ROICexcg growth 5Y39.34%
ROICexc growth 3Y-26.45%
ROICexc growth 5Y39.34%
OM growth 3Y-9.2%
OM growth 5Y41.5%
PM growth 3Y-7.98%
PM growth 5Y49.6%
GM growth 3Y-6.69%
GM growth 5Y30.15%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 40.45%
Interest Coverage 349.27
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 1.63
Altman-Z N/A
F-Score6
WACC16.9%
ROIC/WACC0.99
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)26.7%
Cap/Sales(5y)18.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.36%
EPS 3Y-2.81%
EPS 5Y67.77%
EPS Q2Q%64.61%
EPS Next Y20.31%
EPS Next 2Y22.2%
EPS Next 3Y29.31%
EPS Next 5YN/A
Revenue 1Y (TTM)21.52%
Revenue growth 3Y5.8%
Revenue growth 5Y17.7%
Sales Q2Q%27.84%
Revenue Next Year21.11%
Revenue Next 2Y12.92%
Revenue Next 3Y10.96%
Revenue Next 5YN/A
EBIT growth 1Y44.9%
EBIT growth 3Y-3.93%
EBIT growth 5Y66.55%
EBIT Next Year-2.44%
EBIT Next 3Y15.2%
EBIT Next 5YN/A
FCF growth 1Y-163.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y56.39%
OCF growth 3Y5.46%
OCF growth 5Y44.96%